publication date: Dec. 23, 2010

In this issue: 

Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.

Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.

Caryn Lerman Recruited By Univ. Of Pennsylvania.

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

Impath Buys Clinical Studies Support Services Network.

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

Vasopermeation Technology Awarded Patent For CA Firm.

FDA Approves Xeloda For Breast Cancer Treatment.

Download (PDF 385KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.